author-photo

Raymonde Busch

Technische Universität München
Ludwig Maximilian University of Munich

310

Papers

18859

Citations

Citation Trend

Filter By

Papers (229) Sort By

Journal Conference Others

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (13)
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial.

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (15)
A comprehensive prognostic index for patients with CLL.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial

2017 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (8)
FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia

2017 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (12)
Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group

2016 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (3)
More severe infectious complications in CLL patients treated with fludarabine, cyclophosphamide, rituximab (FCR) in comparison to bendamustin plus rituximab (BR): Results of the interim-analysis of the CLL10 trial of the German CLL Study Group

2014
Show All
- Source
- Cite
- Save
Citations (0)
Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

2014 Blood
Show All
- Source
- Cite
- Save
Citations (98)
PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia

2014 Blood
Show All
- Source
- Cite
- Save
Citations (10)
Obinutuzumab (GA101) plus chlorambucil (Clb) versus rituximab plus Clb in patients with chronic lymphocytic leukaemia (CLL) and comorbidities: recently published results of the CLL11 trial

2014
Show All
- Source
- Cite
- Save
Citations (0)